1)Yamauchi T, Kadowaki T:Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes(Lond)32(Suppl 7):S13-18, 2008
2)Lazar MA:The humoral side of insulin resistance. Nat Med 12:43-44, 2006
3)Weisberg SP, et al:Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808, 2003
4)Xu H, et al:Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830, 2003
5)Wellen KE, Hotamisligil GS:Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785-1788, 2003
6)Springer J, et al:Adiponectin and protection against type 2 diabets melitus. Lancet 361:226-228, 2003
7)Kumada M, et al:Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89, 2003
8)Yamauchi T, et al:The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001
9)Kubota N, et al:Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and-independent pathways. J Biol Chem 281:8748-8755, 2006
10)Dormandy JA, et al:Secondary prevention of macrovascular events in patients with type 2 diabets in the PRO active Study(PRO spective pioglit zone Clinical Trial in macrovascular Events);A randomised controlled trial. Lancet 366:1279-1289, 2005
11)Nomura S, et al:Correlation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabets melitus. Thromb Res 122:39-45, 2008